Oncopeptides AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	749	335	725	1,146	632	11,529
Market Cap Growth	167.60%	-53.79%	-36.76%	81.18%	-94.51%	63.96%
Enterprise Value	749	202	599	724	-39	10,288
Last Close Price	2.75	1.47	5.15	8.16	5.64	114.00
PS Ratio	11.98	10.58	20.58	137.15	5.35	-
PB Ratio	114.50	6.17	12.76	3.89	3.00	19.99
P/TBV Ratio	114.50	6.17	12.76	3.89	3.02	20.05
EV/Sales Ratio	12.00	6.38	17.01	86.70	-	-
Debt / Equity Ratio	22.75	2.61	2.31	0.02	0.07	0.03
Asset Turnover	0.24	0.13	0.11	0.02	0.17	-
Inventory Turnover	0.21	0.78	-	-	-	-
Quick Ratio	3.27	3.74	4.26	4.22	1.78	2.44
Current Ratio	3.42	4.23	4.52	4.25	1.83	2.53
Return on Equity (ROE)	-376.73%	-512.51%	-141.91%	-133.80%	-363.13%	-232.14%
Return on Assets (ROA)	-57.86%	-73.20%	-50.66%	-52.59%	-134.59%	-97.95%
Return on Capital Employed (ROCE)	-158.10%	-146.50%	-130.70%	-115.80%	-697.10%	-256.70%
Earnings Yield	-35.78%	-85.00%	-34.38%	-29.49%	-226.15%	-13.83%
FCF Yield	-30.50%	-77.93%	-38.59%	-36.92%	-239.82%	-11.39%
Buyback Yield / Dilution	-58.45%	-84.14%	-9.80%	-9.33%	-20.72%	-20.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.